Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fiji Kava Limited ( (AU:CCO) ) has issued an announcement.
The Calmer Co. International reported a record monthly revenue of $910,767 for December 2025, the highest in its history, driven by strong growth across Australian grocery, US Amazon and B2B ingredient channels. Wholesale revenue hit a record $340,131, with year-to-date wholesale sales already surpassing the prior financial year, while rising demand for high-kavalactone extracts and recent US regulatory clarification treating traditionally prepared kava beverages as food are expected to support the company’s breakeven trajectory and strengthen its competitive position in the expanding global kava market.
The most recent analyst rating on (AU:CCO) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Fiji Kava Limited stock, see the AU:CCO Stock Forecast page.
More about Fiji Kava Limited
The Calmer Co. International Limited (ASX: CCO) is a fast-growing beverage and consumer packaged goods company focused on kava and other natural products that serve as alternatives to alcohol and support relaxation and sleep. Its portfolio, sold under brands including Fiji Kava, Taki Mai and Danodan Hempworks, spans drinking powders, flavoured and natural kava shots, concentrates and capsules, distributed via e-commerce and major retail partners in the USA, Australia, New Zealand, China and the Pacific Islands through a vertically integrated farm-to-shelf supply chain.
Technical Sentiment Signal: Sell
Current Market Cap: A$10.7M
See more insights into CCO stock on TipRanks’ Stock Analysis page.

